Abstract
Purpose
To evaluate the age-related risk factors, clinical manifestations, and prognosis in infectious keratitis.
Methods
Records of patients with infectious keratitis who visited one of the two tertiary medical centers at Jeolla-do from January 2000 to December 2007 were reviewed. Risk factors depending on patient age distribution standardized over and under the age of 60 were reviewed retrospectively by analyzing sex, age, previous history of trauma, systemic disease, previous ocular disease, causative organism and treatment.
Results
A total of 757 patients (757 eyes) visited either one of the two tertiary medical centers. The mean age was 58.2±18.0 (4 to 93) years, and patients included 437 males (57.7%), and 320 females (42.3%). The most common risk factor among all age groups was trauma, especially due to vegetable matter. The second most frequent risk factor among the younger patients was contact lens use (19.2%), and common risk factors among the elderly were previous ocular disease (20.0%), systemic disease (15.5%), and ocular surgery (9.7%). The most prevalent causative organisms among all age groups were Gram-positive bacteria, in particular Staphylococcus epidermidis. Elderly patients had a higher frequency of corneal perforation than did younger patients. In addition, elderly patients had a worse prognosis and more often required surgical treatment.
Conclusions
Infectious keratitis has more severe clinical manifestations and complications and a worse prognosis in elderly than in younger patients. Elderly patients have more diverse risk factors. Prevention should aim at avoiding ocular trauma, especially by vegetable matter, and at controlling ocular surface diseases, such as exposure keratitis and bullous keratopathy.
References
1. Parmar P, Salman A, Kalavathy CM, et al. Microbial keratitis at extremes of age. Cornea. 2006; 25:153–8.
2. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001; 85:842–7.
3. Bourcier T, Thomas F, Borderie V, et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003; 87:834–8.
4. Van der Meulen IJ, van Rooij J, Nieuwnedaal CP, et al. Age-re-lated risk factors, culture outcomes, and prognosis in patients ad-mitted with infectious keratitis to two Dutch tertiary referral centers. Cornea. 2008; 27:539–44.
5. Kim YS, Lee SB, Chung WS. The causative organisms and therapy of corneal ulcers. J Korean Ophthalmol Soc. 1994; 35:1171–7.
6. Ahn M, Jung YT, Han HJ. A clinical study on infectious corneal ulcer. J Korean Ophthalmol Soc. 1996; 37:1538–43.
7. Hahn YH, Hahn TW, Tchah HW, et al. Epidemiology of infectious keratitis (2): A multi-center study. J Korean Ophthalmol Soc. 2001; 42:247–65.
8. Mukerji N, Vajpayee RB, Sharma N. Technique of area measure-ment of epithelial defects. Cornea. 2003; 22:549–51.
9. Peyman GA, Sanders DR, Goldberg MF. Principles and Practice of Ophthalmology. 2nd ed.Vol. 1. Philadelphia: WB Saunders;1980. p. 285–6.
10. Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbial ker-atitis in South India: influence of risk factors, climate, and geo-graphical variation. Ophthalmic Epidemiol. 2007; 14:61–9.
11. Lee JH, Jung YC. Pathogens of corneal ulcer (II). J Korean Ophthalmol Soc. 1987; 28:31–6.
12. Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J. 1997; 23:275–81.
13. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab. 1992; 18:187–201.
14. Yilmaz S, Ozturk I, Maden A. Microbial keratitis in West Anatolia, Turkey: a retrospective review. Int Ophthalmol. 2007; 27:261–8.
15. Goodman DF, Gottsch JD. Methicillin-resistant Staphylococcus epidermidis keratitis treated with vancomycin. Arch Ophthalmol. 1988; 106:1570–1.
16. Wu PZ, Zhu H, Thakur A, Willcox MD. Comparison of potential pathogenic traits of staphylococci that may contribute to corneal ulceration and inflammation. Aust N Z J Ophthalmol. 1999; 27:234–6.
17. Koidou-Tsiligianni A, Alfonso E, Forster RK. Ulcerative keratitis associated with contact lens wear. Am J ophthalmol. 1989; 108:64–7.
18. Ibrahim YW, Boase DL, Cree IA. Epidemiologic characteristics, predisposing factors and microbiological profile of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol. 2009; 93:1319–24.
19. Toshida H, Kogure N, Inoue N, Murakami A. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007; 33:70–3.
20. Tabbara KF, El-Sheikh HF, Aabed B. Extended wear contact lens related bacterial keratitis. Br J Ophthalmol. 2000; 84:327–8.
21. Park JH, Lee SB. Analysis on inpatients with infectious keratitis: causative organisms, clinical aspects and risk factors. J Korean Ophthalmol Soc. 2009; 50:1152–66.
22. Butler TK, Spencer NA, Chan CC, et al. Infective keratitis in old-er patients: a 4 year review, 1998-2002. Br J Ophthalmol. 2005; 89:591–6.
23. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006; 113:109–16.
Table 1.
Variable | CUH* patients | CNUH† patients | Younger patients (<60 years) | Elderly patients (≥60 years) |
---|---|---|---|---|
No. of visited patients (%) | 318 (42.0) | 439 (58.0) | 313 (41.3) | 444 (58.7) |
Age (years) | ||||
Mean± SD‡ | 58.2±18.3 | 58.2±17.4 | 41.5±14.6 | 70.2±7.1 |
Range | (7-89) | (4-93) | (4-59) | (60-93) |
Sex | ||||
Male | 182 (57.2) | 255 (58.1) | 197 (62.9) | 240 (54.1) |
Female | 136 (42.8) | 184 (41.9) | 116 (37.1) | 204 (45.9) |
Table 2.
Table 3.
Preexisting ocular diseases |
Younger patients (<60 years) [n (%)] |
Elderly patients (≥60 years) [n (%)] |
P value |
---|---|---|---|
Lagophthalmos (exposure keratitis) | 9 (2.9) | 22 (5.0) | 0.003 |
Bullous keratopathy | 5 (1.6) | 20 (4.5) | 0.028 |
Previous keratitis | 11 (3.5) | 14 (3.2) | 0.784 |
Herpetic keratitis | 10 (3.2) | 14 (3.2) | 0.974 |
Trichiasis | 5 (1.6) | 4 (0.9) | 0.384 |
Conjunctivitis | 4 (1.3) | 0 (0.0) | N-S* |
Dry eye syndrome | 0 (0.0) | 2 (0.5) | N-S* |
Blepharitis | 0 (0.0) | 2 (0.5) | N-S* |
Stevens-Johnson syndrome | 2 (0.6) | 0 (0.0) | N-S* |
Dacryocystitis | 0 (0.0) | 1 (0.2) | N-S* |
Other | 0 (0.0) | 11 (2.5) | N-S* |
Table 4.
Table 5.
Organisms |
Younger patients (<60 years) [n (%)] |
Elderly patients (≥60 years) [n (%)] |
] P value |
---|---|---|---|
Gram (+) bacteria | 163 (60.1) | 258 (61.7) | 0.100 |
Gram (+) cocci | |||
Staphylococcus species | 63 (23.2) | 70 (16.7) | 0.013 |
Staphylococcus aureus | 11 (4.1) | 14 (3.3) | 0.576 |
Staphylococcus epidermidis | 29 (10.7) | 34 (8.1) | 0.196 |
Other coagulase negative staphylococc | ci 23 (8.5) | 22 (5.3) | 0.071 |
Streptococcus species | 16 (5.9) | 39 (9.3) | 0.116 |
Viridans streptococcus | 7 (2.6) | 17 (4.1) | 0.011 |
Streptococcus pneumoniae | 5 (1.8) | 19 (4.5) | 0.064 |
Other streptococcus | 4 (1.5) | 3 (0.7) | 0.313 |
Enterococcus faecalis | 0 (0.0) | 2 (0.5) | N-S* |
Gram (+) bacilli | |||
Bacillus species | 1 (0.4) | 3 (0.7) | 0.571 |
Corynebacterium species | 1 (0.4) | 1 (0.2) | 0.743 |
Other | 3 (1.1) | 14 (3.3) | 0.069 |
Gram (−) bacteria | 33 (12.2) | 41 (9.8) | 0.550 |
Gram (−) rod | |||
Pseudomonas species | 11 (4.1) | 14 (3.3) | 0.941 |
Serratia marcescens | 8 (3.0) | 0 (0.0) | 0.001 |
Burkholderia cepacia | 3 (1.1) | 4 (1.0) | 0.923 |
Klebsiella species | 1 (0.4) | 6 (1.4) | 0.090 |
Enterobacter cloacae | 1 (0.4) | 4 (1.0) | 0.252 |
Stenotrophomonas maltophilia | 1 (0.4) | 5 (1.2) | 0.151 |
Proteus mirabilis | 0 (0.0) | 2 (0.5) | N-S* |
Moraxella lacunata | 0 (0.0) | 2 (0.5) | N-S* |
Other | 8 (3.0) | 4 (1.0) | 0.093 |
Fungus | 74 (27.3) | 119 (28.5) | 0.326 |
Nonpigmented (Hyaline) filamentous fungi | 26 (9.6) | 40 (9.6) | 0.828 |
Fusarium species | 16 (5.9) | 29 (6.9) | 0.661 |
Aspergillus species | 9 (3.3) | 7 (1.7) | 0.124 |
Penicillium species | 1 (0.4) | 3 (0.7) | 0.579 |
Beauveria species | 0 (0.0) | 1 (0.2) | N-S* |
Pigmented (Dematiacious) filamentous fungi | 2 (0.8) | 14 (3.3) | 0.067 |
Alternaria species | 0 (0.0) | 11 (2.6) | 0.007 |
Cladosporium species | 1 (0.4) | 3 (0.7) | 0.579 |
Curvularia species | 1 (0.4) | 0 (0.0) | N-S* |
Other mold-like fungi | 12 (4.4) | 9 (2.2) | 0.071 |
Yeast | 4 (1.5) | 8 (1.9) | 0.713 |
Candida species | 3 (1.1) | 4 (1.0) | 0.802 |
Trichosporon species | 0 (0.0) | 3 (0.7) | N-S* |
Rhodotorula species | 1 (0.4) | 1 (0.2) | 0.733 |
Acanthamoeba | 1 (0.4) | 0 (0.0) | N-S* |
Total | 271 | 418 |
Table 6.
Surgical interventions | Younger patients (<60 years) [n (%)] | Elderly patients (≥60 years) [n (%)] | P value |
---|---|---|---|
Amniotic membrane transplantation | 38 (12.1) | 94 (21.2) | 0.001 |
Evisceration or enucleation | 11 (3.5) | 47 (10.6) | 0.006 |
Penetrating keratoplasty | 21 (6.7) | 22 (5.0) | 0.304 |
Partial or complete conjunctival flap | 0 (3.2) | 11 (2.5) | 0.005 |
Scleral graft | 1 (0.3) | 10 (2.3) | 0.029 |
Application of histoacryl glue | 4 (1.3) | 5 (1.1) | 0.849 |
Tarsorrhaphy | 1 (0.3) | 7 (1.6) | 0.096 |
Lamellar keratoplasty | 0 (0.0) | 5 (1.1) | 0.066 |
Anterior chamber irrigation | 1 (0.3) | 1 (0.2) | 0.109 |
Dacryocystorhinostomy | 0 (0.0) | 1 (0.2) | N-S* |